Genzyme
Sign in to saveAlso known as Sanofi Genzyme
Genzyme (also known as Genzyme Transgenics Corp or GTC Biotherapeutics) was an American biotechnology company based in Cambridge, Massachusetts. From its acquisition in 2011 to 2022 Genzyme operated as a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world's third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme had a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products were also sold in 90 countries. In 2007, Genzyme generated $3.8 billion
Key facts
- Company.name
- Genzyme
- Company.image
- Genzyme building.jpg
- Company.image_caption
- Sanofi Genzyme headquarters in Cambridge, Massachusetts in 2007
- Company.logo
- Genzyme logo.svg
- Company.type
- Subsidiary
- Company.foundation
- , in Boston, Massachusetts
- Company.location_city
- Cambridge, Massachusetts
- Company.location_country
- United States
- Company.industry
- Biotechnology
- Company.products
- Cerezyme Fabrazyme Synvisc Renagel More Complete Product List
- Company.revenue
- US $4.61 billion (2007 calendar)
- Company.operating_income
- US $581 million (2007 calendar)
- Company.net_income
- US $421 million (2007 calendar)
- Company.num_employees
- 12,000 (2010)
- Company.parent
- Sanofi
via Wikipedia infobox
Wikidata facts
- Instance of
- enterprise
- Country
- United States
- Headquarters
- Cambridge
- Owned by
- Sanofi
- Parent organization
- Sanofi
- Industry
- pharmaceutical industry
- Legal form
- public limited company
- Official website
- www.genzyme.com
- Image
- Genzyme building.jpg
Show 7 more facts
- inception
- 1981-01-01
- location of formation
- Boston
- Commons category
- Genzyme
- product or material produced
- imiglucerase
- social media followers
- 58517
- dissolved, abolished or demolished date
- 2022-02-00
- merged into
- Sanofi
Sources (6)
via Wikidata · CC0
Article · Italiano
Genzyme Corporation (NASDAQ: GENZ) è una società con sede a Cambridge.Genzyme è la terza più grande compagnia di biotecnologie al mondo con oltre 9.000 lavoratori nel mondo.Attualmente, la società ha approssimativamente 80 ubicazioni in 40 paesi.Include 17 strutture di produzione e 9 laboratori di test di genetica. In data 16 febbraio 2011 viene dato l'annuncio della acquisto di Genzyme da parte di Sanofi Aventis. Genzyme è l'azienda che produce e sperimenta l'alemtuzumab, il farmaco mostra promettenti sviluppi nella sclerosi multipla oltre all'indicazione approvata: cronica.
Abstract from DBpedia / Wikipedia · CC BY-SA